240 related articles for article (PubMed ID: 15848052)
1. Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer.
Lopes LB; Collett JH; Bentley MV
Eur J Pharm Biopharm; 2005 May; 60(1):25-30. PubMed ID: 15848052
[TBL] [Abstract][Full Text] [Related]
2. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.
Lopes LB; Ferreira DA; de Paula D; Garcia MT; Thomazini JA; Fantini MC; Bentley MV
Pharm Res; 2006 Jun; 23(6):1332-42. PubMed ID: 16715364
[TBL] [Abstract][Full Text] [Related]
3. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery.
Lopes LB; Lopes JL; Oliveira DC; Thomazini JA; Garcia MT; Fantini MC; Collett JH; Bentley MV
Eur J Pharm Biopharm; 2006 Jun; 63(2):146-55. PubMed ID: 16621488
[TBL] [Abstract][Full Text] [Related]
4. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
Liu H; Li S; Wang Y; Yao H; Zhang Y
Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems.
Lopes LB; Speretta FF; Bentley MV
Eur J Pharm Sci; 2007 Nov; 32(3):209-15. PubMed ID: 17900879
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations.
Herai H; Gratieri T; Thomazine JA; Bentley MV; Lopez RF
Int J Pharm; 2007 Feb; 329(1-2):88-93. PubMed ID: 17027205
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers.
Lopes LB; Murphy N; Nornoo A
Pharm Dev Technol; 2009; 14(5):524-9. PubMed ID: 19552564
[TBL] [Abstract][Full Text] [Related]
8. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway.
Simonetti LD; Gelfuso GM; Barbosa JC; Lopez RF
Eur J Pharm Biopharm; 2009 Sep; 73(1):90-4. PubMed ID: 19442727
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the potential of electroporation facilitated topical delivery of cyclosporin a.
Liu HZ; Wang YJ; Xu L; Li SM
PDA J Pharm Sci Technol; 2010; 64(3):191-9. PubMed ID: 21502019
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide.
Lopes LB; Brophy CM; Furnish E; Flynn CR; Sparks O; Komalavilas P; Joshi L; Panitch A; Bentley MV
Pharm Res; 2005 May; 22(5):750-7. PubMed ID: 15906170
[TBL] [Abstract][Full Text] [Related]
12. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin.
Steluti R; De Rosa FS; Collett J; Tedesco AC; Bentley MV
Eur J Pharm Biopharm; 2005 Aug; 60(3):439-44. PubMed ID: 15996585
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of in-vivo transdermal absorption of cyclosporin with absorption enhancer using intradermal microdialysis in rats.
Nakashima M; Zhao MF; Ohya H; Sakurai M; Sasaki H; Matsuyama K; Ichikawa M
J Pharm Pharmacol; 1996 Nov; 48(11):1143-6. PubMed ID: 8961162
[TBL] [Abstract][Full Text] [Related]
14. A preformulation strategy for the selection of penetration enhancers for a transungual formulation.
Palliyil B; Lebo DB; Patel PR
AAPS PharmSciTech; 2013 Jun; 14(2):682-91. PubMed ID: 23572254
[TBL] [Abstract][Full Text] [Related]
15. Bicontinuous cyclosporin a loaded water-AOT/Tween 85-isopropylmyristate microemulsion: structural characterization and dermal pharmacokinetics in vivo.
Liu H; Wang Y; Lang Y; Yao H; Dong Y; Li S
J Pharm Sci; 2009 Mar; 98(3):1167-76. PubMed ID: 18729203
[TBL] [Abstract][Full Text] [Related]
16. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of Cyclosporine A into the skin using SPACE-peptide.
Chen M; Kumar S; Anselmo AC; Gupta V; Slee DH; Muraski JA; Mitragotri S
J Control Release; 2015 Feb; 199():190-7. PubMed ID: 25481447
[TBL] [Abstract][Full Text] [Related]
18. Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A.
Liu H; Li S; Pan W; Wang Y; Han F; Yao H
Int J Pharm; 2006 Dec; 326(1-2):32-8. PubMed ID: 16949776
[TBL] [Abstract][Full Text] [Related]
19. Topical administration of cyclosporin A in a solid lipid nanoparticle formulation.
Kim ST; Jang DJ; Kim JH; Park JY; Lim JS; Lee SY; Lee KM; Lim SJ; Kim CK
Pharmazie; 2009 Aug; 64(8):510-4. PubMed ID: 19746839
[TBL] [Abstract][Full Text] [Related]
20. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
